Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Bright Minds Biosciences Inc. (DRUG) had Stock-Based Compensation of $0.92M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-5.43M |
|
-- |
|
-- |
|
$4.95M |
|
$-4.95M |
|
$-0.47M |
|
$-5.43M |
|
$-5.43M |
|
$-5.43M |
|
$-5.43M |
|
$-5.43M |
|
$-5.43M |
|
$-4.95M |
|
$-4.94M |
|
7.76M |
|
7.76M |
|
$-0.70 |
|
$-0.70 |
|
| Balance Sheet Financials | |
$65.12M |
|
-- |
|
$0.07M |
|
$65.19M |
|
$1.14M |
|
$0.01M |
|
$0.01M |
|
$1.15M |
|
$64.04M |
|
$64.04M |
|
$64.04M |
|
7.79M |
|
| Cash Flow Statement Financials | |
$-4.17M |
|
-- |
|
$9.61M |
|
$59.47M |
|
$63.87M |
|
$4.40M |
|
|
Stock-Based Compensation |
$0.92M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
57.37 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.47% |
|
-8.47% |
|
-8.32% |
|
-8.47% |
|
$8.22 |
|
$-0.54 |
|
$-0.54 |
|